4.7 Article

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

Journal

GENES & DEVELOPMENT
Volume 25, Issue 3, Pages 226-231

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.1974211

Keywords

miR-335; metastasis; genetic; tumor intiation; ovarian; epigenetic

Funding

  1. Rita Allen
  2. Anderson Cancer Center
  3. Sidney Kimmel
  4. ASCO
  5. Meyer
  6. Sinsheimer
  7. Emerald foundations
  8. Breast Cancer Alliance
  9. Hess family
  10. DOD
  11. National Institutes of Health
  12. Hearst Foundation
  13. Kleberg Foundation

Ask authors/readers for more resources

Post-transcriptional regulators have emerged as robust effectors of metastasis and display deregulated expression through unknown mechanisms. Here, we reveal that the human microRNA-335 locus undergoes genetic deletion and epigenetic promoter hypermethylation in every metastatic derivative obtained from independent patients' malignant cell populations. Genetic deletion of miR-335 is a common event in human breast cancer, is enriched for in breast cancer metastases, and also correlates with ovarian cancer recurrence. We furthermore identify miR-335 as a robust inhibitor of tumor reinitiation. We thus implicate the miR-335 locus on 7q32.2 as the first selective metastasis suppressor and tumor initiation suppressor locus in human breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available